SamA Pharmaceutical Co., Ltd
Quick facts
Marketed products
- Atock Dry Syrup with placebo patch
Atock Dry Syrup is a medication that works by providing a placebo effect through its patch, which does not contain any active ingredients. - PRIC · Other
- Tulobuterol patch with placebo dry syrup · Respiratory
Tulobuterol is a beta-2 adrenergic agonist that stimulates beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow.
Phase 3 pipeline
- Active Comparator Control 1
Active Comparator Control 1 is a pharmacologically inactive substance used as a control in clinical trials. - Active Comparator Control 2
Active Comparator Control 2 is a drug that acts as a control in clinical trials. - CITUS Dry Syrup · Infectious Diseases
CITUS Dry Syrup is a medication that works by inhibiting the action of a specific enzyme. - Pranlukast hydrate · Respiratory
Pranlukast hydrate is a leukotriene receptor antagonist that inhibits the action of leukotrienes, which are involved in the inflammatory process.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about SamA Pharmaceutical Co., Ltd
What are SamA Pharmaceutical Co., Ltd's marketed drugs?
Top marketed products include Atock Dry Syrup with placebo patch, PRIC, Tulobuterol patch with placebo dry syrup.
What is SamA Pharmaceutical Co., Ltd's pipeline?
SamA Pharmaceutical Co., Ltd has 4 drugs in Phase 3, 2 in Phase 2, 0 in Phase 1. Late-stage candidates include Active Comparator Control 1, Active Comparator Control 2, CITUS Dry Syrup, Pranlukast hydrate.
Related
- Atock Dry Syrup with placebo patch
- PRIC · Other
- Tulobuterol patch with placebo dry syrup · Respiratory
- Sector hub: All tracked pharma companies